Renalytix PLC (RNLX)
0.5117
-0.08
(-13.11%)
USD |
NASDAQ |
May 17, 16:00
0.5117
0.00 (0.00%)
After-Hours: 20:00
Renalytix 1 Year Total Returns (Daily): -75.27% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -75.27% |
May 16, 2024 | -72.61% |
May 15, 2024 | -74.11% |
May 14, 2024 | -69.91% |
May 13, 2024 | -71.99% |
May 10, 2024 | -74.61% |
May 09, 2024 | -74.87% |
May 08, 2024 | -74.36% |
May 07, 2024 | -71.08% |
May 06, 2024 | -71.13% |
May 03, 2024 | -68.88% |
May 02, 2024 | -67.00% |
May 01, 2024 | -63.59% |
April 30, 2024 | -70.76% |
April 29, 2024 | -71.48% |
April 26, 2024 | -73.24% |
April 25, 2024 | -70.97% |
April 24, 2024 | -72.11% |
April 23, 2024 | -69.88% |
April 22, 2024 | -67.85% |
April 19, 2024 | -67.92% |
April 18, 2024 | -67.83% |
April 17, 2024 | -66.26% |
April 16, 2024 | -66.75% |
April 15, 2024 | -66.02% |
Date | Value |
---|---|
April 12, 2024 | -62.95% |
April 11, 2024 | -62.12% |
April 10, 2024 | -64.87% |
April 09, 2024 | -64.62% |
April 08, 2024 | -66.62% |
April 05, 2024 | -66.39% |
April 04, 2024 | -66.66% |
April 03, 2024 | -65.58% |
April 02, 2024 | -64.88% |
April 01, 2024 | -65.90% |
March 28, 2024 | -60.37% |
March 27, 2024 | -60.94% |
March 26, 2024 | -57.31% |
March 25, 2024 | -56.20% |
March 22, 2024 | -49.14% |
March 21, 2024 | -53.49% |
March 20, 2024 | -56.67% |
March 19, 2024 | -55.36% |
March 18, 2024 | -53.57% |
March 15, 2024 | -62.61% |
March 14, 2024 | -61.78% |
March 13, 2024 | -64.22% |
March 12, 2024 | -61.15% |
March 11, 2024 | -51.28% |
March 08, 2024 | -61.62% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-95.89%
Minimum
Oct 21 2022
149.1%
Maximum
Oct 21 2021
-38.65%
Average
-64.75%
Median
1 Year Total Returns (Daily) Benchmarks
TC BioPharm (Holdings) PLC | -93.27% |
Ainos Inc | -70.37% |
Aptorum Group Ltd | 30.14% |
Adaptimmune Therapeutics PLC | -17.16% |
Biodexa Pharmaceuticals Plc | -93.53% |